Skip to main content Skip to navigation
Menu
Access myPennMedicine

Spring 2023

An illustration with a colorful blue-red gradient has curving shapes representing the flow of time with icons representing cells, DNA, molecules, a syringe, etc.

Why Medical Advancements at Penn Power FDA Approved Treatments

Since 2017, the FDA has approved more than two dozen new therapies with roots at Penn Medicine — almost half of which are first-in-class for their indications. Becoming a hub for drug research and development took a lot more than luck.

The Pennovation Center, a wide brick building with angular glass shapes jutting from one end and the word “Pennovation” in large letters above the roofline.

The Path from Innovation to Implementation

Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from ideas to FDA-approved therapies.

Sunil Singhal, MD, examines lung tissue during a surgical procedure using a glowing tumor agent, while a colleague observes.

Why New Cancer Treatment Discoveries are Proliferating

There are fewer cancer deaths and more cancer therapies than ever, in part because scientists now design drugs to attack cancer based on its biology.

Curving shapes on a red/blue gradient background with icons indicating drugs, populations, and outreach.

Putting Biomedical Research Advances Within Reach

While driving biomedical innovation and new therapies, Penn pushes for equity to make vaccines and treatments available and accessible to more people.

  • A young woman sprinkles sand onto the hand of a girl around 4 years old, held above a plastic bin.

    The Ability Academy: A Partnership for Autism-Inclusive Preschool

    When fully operational, the Ability Academy at Penn will be able to meet the needs of 225 children, offering both full and half-day preschool.
  • A colorful array of cancer signaling proteins against a white background

    In the Pocket

    Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine.

Cover of Penn Medicine magazine with headline “Putting Discoveries to Work”

Subscribe to emails

Download PDF

In This Issue:

Why Medical Advancements at Penn Power Many FDA-Approved Treatments

The Path from Innovation to Implementation

Why New Cancer Treatment Discoveries are Proliferating

Putting Biomedical Research Advances Within Reach

Can We Intercept Cancer? A New Frontier in Cancer Research

PennHealthX: At the Crossroads of Medicine, Business & Tech

How Penn Medicine is Serving a Changing World

A Port in the Storm

Seeing Penn Through New Eyes

Penn Medicine and Wharton Invest for Public Health Impact

Decades in Pursuit of a Diabetes Cure

Penn Hematology/Oncology Enters its Next Chapter

Very Personal Care — Made Possible By Very Personal Philanthropy

Growing a Penn Med Family Bound by Service

The Ability Academy: A Partnership for Autism-Inclusive Preschool

In the Pocket

Share This Page:
Post Tweet Share